Ehlers-Danlos syndrome (EDS) is a group of genetic disorders where the connective tissue that supports the skin, bones, blood vessels and other organs and tissues fails to form properly, due to mutations in genes that produce the fibrous proteins and enzymes that make collagen. EDS affects approximately 1 in every 5,000 people globally. It is thought that around 10,000,000 Americans are affected. For those coming out of surgery and/or chronic pain due to EDS, cannabis represents a possible alternative to opioids and powerful NSAIDs.
Explorar las condiciones A-Z
Cannabis para Síndrome de Ehlers-Danlos (SED)
Research Overview
Clinical Trial
2
Double Blind Clinical Trial
2
Metanálisis
3
Total de estudios
Síndrome de Ehlers-Danlos (SED)
7
Positive
5 estudios
72%
Inconclusive
1 estudios
14%
Negative
1 estudios
14%
Do I qualify?
Select your state from the drop down and we’ll let you know.
Relevant studies
The information in our comprehensive A to Z encyclopedia comes from real scientific studies.
Uncover the detailed results of these studies and find out how effective medical marijuana is for dozens of conditions.
- Cannabis-Induced ST-Segment Elevation Myocardial Infarction With Possible Coronary Artery Dissection: A Case Report
- Effects of intravenous tetrahydrocannabinol on experimental and surgical pain. Psychological correlates of the analgesic response.
- Evaluation of the effects of CBD hemp extract on opioid use and quality of life indicators in chronic pain patients: a prospective cohort study
- Preliminary assessment of the efficacy, tolerability and safety of a cannabis-based medicine (Sativex) in the treatment of pain caused by rheumatoid arthritis
- Preliminary evaluation of the efficacy, safety, and costs associated with the treatment of chronic pain with medical cannabis